drospirenone and ethinyl estradiol

FDA Drug Profile — DROSPIRENONE AND ETHINYL ESTRADIOL, Nikki, drospirenone and ethinyl estradiol, Yasmin, OCELLA

Drug Details

Generic Name
drospirenone and ethinyl estradiol
Brand Names
DROSPIRENONE AND ETHINYL ESTRADIOL, Nikki, drospirenone and ethinyl estradiol, Yasmin, OCELLA
Application Number
ANDA202131
Sponsor
Mylan Pharmaceuticals Inc.
NDC Codes
9
Dosage Forms
KIT
Routes
N/A
Active Ingredients
N/A

Indications and Usage

1 INDICATIONS AND USAGE Zumandimine ® (drospirenone and ethinyl estradiol tablets) are indicated for use by females of reproductive potential to prevent pregnancy. Zumandimine (drospirenone and ethinyl estradiol tablets) is a combination of drospirenone, a progestin, and ethinyl estradiol, an estrogen, indicated for use by females of reproductive potential to prevent pregnancy. ( 1 )